000			01503nam a2200433Ka 4500
001			ocn844975955
003			OCoLC
005			20240729131221.0
006			m d
007			cr cnu---unuuu
008			130529s2012 nyu ob 001 0 eng d
040			_aN$T _cN$T
020			_a9781620818268 (electronic bk.)
020			_a1620818264 (electronic bk.)
020			_z9781620818138
020			_z1620818132
035			_a(OCoLC)844975955
035			_a581786 _b(N$T)
072		7	_aMED _x093000 _2bisacsh
072		7	_aMED _x105020 _2bisacsh
049			_aN$TA
245	0	0	_aSynthetic drugs _h[electronic resource] : _bscope and trends in synthetic cannabinoids and stimulants _c
260			_aHauppauge, N.Y. : _bNova Science ; _aLancaster : _bGazelle [distributor], _c2012.
300			_a1 online resource (xi, 122 p.) : _bill.
490	1		_aSubstance abuse assessment, interventions and treatment
490	1		_aDrug transit and distribution, interception and control
504			_aIncludes bibliographical references and index.
588			_aDescription based on print version record.
650		0	_aDesigner drugs.
700	1		_aGray, Terrence L.
700	1		_aEvans, Sage F.
830		0	_aSubstance abuse assessment, interventions and treatment.
830		0	_aDrug transit and distribution, interception and control.
856			_u#gotoholdings _yAccess resource
938			_aEBSCOhost _bEBSC _n581786
910			_acpp1723AUTO
942			_n0
994			_a02 _bN$T
999			_c91203 _d91203